Drug class in one race
dopamine precursor drugs for Parkinson's Disease
10 tracked dopamine precursor drugs in the Parkinson's Disease race. The class explanation lives on the dopamine precursor page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
6 approved / phase 41 Phase 32 Phase 21 Phase 1/2
Head-to-head evidence: Crexont (IPX203) vs Inbrija (CVT-301) · Crexont (IPX203) vs Levodopa-carbidopa intestinal gel · Crexont (IPX203) vs Melevodopa/carbidopa (Sirio) · Crexont (IPX203) vs ND0612 · Crexont (IPX203) vs Parcopa · Crexont (IPX203) vs Rytary (IPX066)